249 related articles for article (PubMed ID: 24471561)
1. Clinical evaluation of an automated artificial pancreas using zone-model predictive control and health monitoring system.
Harvey RA; Dassau E; Bevier WC; Seborg DE; Jovanovič L; Doyle FJ; Zisser HC
Diabetes Technol Ther; 2014 Jun; 16(6):348-57. PubMed ID: 24471561
[TBL] [Abstract][Full Text] [Related]
2. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
[TBL] [Abstract][Full Text] [Related]
3. Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.
Zisser H; Renard E; Kovatchev B; Cobelli C; Avogaro A; Nimri R; Magni L; Buckingham BA; Chase HP; Doyle FJ; Lum J; Calhoun P; Kollman C; Dassau E; Farret A; Place J; Breton M; Anderson SM; Dalla Man C; Del Favero S; Bruttomesso D; Filippi A; Scotton R; Phillip M; Atlas E; Muller I; Miller S; Toffanin C; Raimondo DM; De Nicolao G; Beck RW;
Diabetes Technol Ther; 2014 Oct; 16(10):613-22. PubMed ID: 25003311
[TBL] [Abstract][Full Text] [Related]
4. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.
Grosman B; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
J Diabetes Sci Technol; 2010 Jul; 4(4):961-75. PubMed ID: 20663463
[TBL] [Abstract][Full Text] [Related]
5. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
[TBL] [Abstract][Full Text] [Related]
6. Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals.
Cameron F; Niemeyer G; Wilson DM; Bequette BW; Benassi KS; Clinton P; Buckingham BA
Diabetes Technol Ther; 2014 Nov; 16(11):728-34. PubMed ID: 25259939
[TBL] [Abstract][Full Text] [Related]
7. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
[TBL] [Abstract][Full Text] [Related]
8. Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.
Pinsker JE; Lee JB; Dassau E; Seborg DE; Bradley PK; Gondhalekar R; Bevier WC; Huyett L; Zisser HC; Doyle FJ
Diabetes Care; 2016 Jul; 39(7):1135-42. PubMed ID: 27289127
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R
J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834
[TBL] [Abstract][Full Text] [Related]
10. Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project.
Nimri R; Atlas E; Ajzensztejn M; Miller S; Oron T; Phillip M
Diabetes Technol Ther; 2012 Aug; 14(8):728-35. PubMed ID: 22853723
[TBL] [Abstract][Full Text] [Related]
11. An integrated multivariable artificial pancreas control system.
Turksoy K; Quinn LT; Littlejohn E; Cinar A
J Diabetes Sci Technol; 2014 May; 8(3):498-507. PubMed ID: 24876613
[TBL] [Abstract][Full Text] [Related]
12. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
[TBL] [Abstract][Full Text] [Related]
13. Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement.
Turksoy K; Bayrak ES; Quinn L; Littlejohn E; Cinar A
Diabetes Technol Ther; 2013 May; 15(5):386-400. PubMed ID: 23544672
[TBL] [Abstract][Full Text] [Related]
14. Artificial pancreas using a personalized rule-based controller achieves overnight normoglycemia in patients with type 1 diabetes.
Capel I; Rigla M; García-Sáez G; Rodríguez-Herrero A; Pons B; Subías D; García-García F; Gallach M; Aguilar M; Pérez-Gandía C; Gómez EJ; Caixàs A; Hernando ME
Diabetes Technol Ther; 2014 Mar; 16(3):172-9. PubMed ID: 24152323
[TBL] [Abstract][Full Text] [Related]
15. Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System's Fuzzy Logic Controller.
Mauseth R; Lord SM; Hirsch IB; Kircher RC; Matheson DP; Greenbaum CJ
J Diabetes Sci Technol; 2015 Sep; 9(6):1253-9. PubMed ID: 26370244
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a Predictive Low-Glucose Management System In-Clinic.
Buckingham BA; Bailey TS; Christiansen M; Garg S; Weinzimer S; Bode B; Anderson SM; Brazg R; Ly TT; Kaufman FR
Diabetes Technol Ther; 2017 May; 19(5):288-292. PubMed ID: 28221823
[TBL] [Abstract][Full Text] [Related]
17. Internal model control based module for the elimination of meal and exercise announcements in hybrid artificial pancreas systems.
Sala-Mira I; Garcia P; Díez JL; Bondia J
Comput Methods Programs Biomed; 2022 Nov; 226():107061. PubMed ID: 36116400
[TBL] [Abstract][Full Text] [Related]
18. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
Garg S; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
Diabetes Technol Ther; 2012 Mar; 14(3):205-9. PubMed ID: 22316089
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise.
Pinsker JE; Laguna Sanz AJ; Lee JB; Church MM; Andre C; Lindsey LE; Doyle FJ; Dassau E
Diabetes Technol Ther; 2018 Jul; 20(7):455-464. PubMed ID: 29958023
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.
Dassau E; Renard E; Place J; Farret A; Pelletier MJ; Lee J; Huyett LM; Chakrabarty A; Doyle FJ; Zisser HC
Diabetes Obes Metab; 2017 Dec; 19(12):1698-1705. PubMed ID: 28474383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
